Study S000773

Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in a Sub Saharan African Population With Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT02832999
Acronym: LIRAVIS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: COMPLETED
Enrollment: 14
Start: 2016-01
Primary completion: 2016-09
Lead sponsor: Yaounde Central Hospital
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:sub cutaneous liraglutide; DRUG:Oral Vildagliptin
Results posted: FALSE

Registered primary outcomes

Insulin sentivity [2 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.